Market Cap (In JPY)
1.35 Billion
Revenue (In JPY)
1.71 Billion
Net Income (In JPY)
26.37 Million
Avg. Volume
9591.00
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 325.0-580.0
- PE
- -
- EPS
- -
- Beta Value
- 0.331
- ISIN
- JP3803010002
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Takashi Shimada
- Employee Count
- -
- Website
- https://www.phoenixbio.co.jp
- Ipo Date
- 2016-03-18
- Details
- PhoenixBio Co., Ltd. provides contract study services for drug discovery and development primarily in Japan. The company uses PXB-mouse, a chimeric mouse with a humanized liver for use in drug development experiments; and in vitro studies using fresh human hepatocytes taken from PXB-cells. The chimeric mouse model with a humanized liver is used for in vivo studies in gene therapeutics, NASH/NAFLD drug development programs, anti-viral therapeutic tests, DMPK/toxicity studies, and custom transplantations. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.
More Stocks
-
YEWTF
-
001213
-
NTOIYNeste Oyj
NTOIY
-
GUD
-
KEX
-
EHGRF
-
PHN
-
600567